Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-4071116

  • Global Ortho Biological Products Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: November 2016 | Report Code: HPH-4071116

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The global ortho biological products market is anticipated to grow to $15.4 billionduring 2016-2022 as a result of significant growth in the medical devices industry especially owing to rising in aging population. Rising of ortho biological products is driven by growing awareness towards adoption of orthobiologics, development in technology, and increasing number of orthopedic related process. 

 As population continues to rise, there is immediate rise in aging population which is contributing towards the increasing orthobiological products industry as there is requirement of orthopedic procedures is higher in such elderly population. Many factors driving the growth of this market also include number of obese patients with increasing levels of osteoarthritis and rheumatoid arthritis and patients with demand for cartilage repair procedures. Also, there are rising occurrences of diseases like diabetes which is leading to slower bone and tissue healing, thus ensuing in rising numbers of trauma and sport related injuries.

The segments of the ortho biological products market are on the basis of the applications, products, and region. The products market segmentation is on the basis of Demineralized Bone Matrix, machined bones, allograft, Bone Morphogenetic Protein, machined bones, stem cell therapy, visco supplementation, and other applications. Visco supplementation holds the largest market share and is anticipated to maintain the current growth path during the coming period. Increasing popularity of visco supplementation over other products is due to their superior performance and benefits perceived by the patients. Visco supplements are witnessed to provide long lasting pain relief than other treatments. The fastest growing segment in products segment is anticipated to be of the stem cell therapy. The driving forces for this growth are projected to be advantages like reduction in cost of treatment, improved healing process, and fast recovery time.

On the basis of applications, the market is segmented into trauma, spinal fusion, reconstructive surgeries, tendon & ligament repair, and other application. Spinal fusion holds the major market share and is estimated to retain its position during the coming period. The factors helping the growth are rising aging population which requires the spinal fusion surgeries and the increasing prevalence of spinal injuries. Reconstructive surgeries are anticipated to show the rapid growth in the application segment because of technological innovations and growing popularity of cosmetic treatments.

The market is facing specific restraint such as high cost associated with the products. These products has high costs, that are beyond the affordability of few people and it is restricting the growth of the market. The market has lots of potential opportunities with the increasing  demand from emerging markets like china, Brazil, India, etc., increasing healthcare spending by people across geographies and rising medical tourism. The dearth of skilled professionals is major challenge which is faced by the market

On the basis of geography, the global market of ortho biological products is segmented into North America, Europe, Asia Pacific and Rest of the world. The North America is the leading region of ortho biological products Market. The market expansion and the lead is expected to sustain during the coming  period due  to the increasing population base of geriatric patients,  increasing prevalence of injuries, increasing medical device sales and growing  number of orthopedic procedures. Another factor contributing to the major growth of the region is the rising prevalence of orthopedic disorders like rheumatoid arthritis and osteoporosis. Europe has the second highest share in the market and is anticipated to maintain its place over the coming period. Germany is projected to be the country to show highest growth in Europe owing to the presence of multiple healthcare companies, increasing awareness level of patients regarding ortho biological products and growing geriatric population base. Asia Pacific is expected to be the rapidly growing region with specific emphasis on South Korea, Malaysia, China, and India. The drivers for the profitable growth in the region are attributed to the rising disposal income of people, increasing expenditure power of the patients over healthcare, rising medical tourism to these nations, and growing awareness level of the patients. Technological innovations and government initiatives are expected to further increase the growth of the market in the region with presence of market growth oriented policies and strategies.

Major players overwhelming the ortho biological products business sector are Bioventus, Pioneer Surgical Technology, Baxter International, Inc., Smith and Nephew Plc, DePuySynthes, Inc., Allograft Tissue Systems, Bone Biologics, Inc., Integra Life Sciences Corp., Bone Solutions, Inc., Sanofi, Tissue Banks Osiris Therapeutics, Inc., International, Medtronic, Inc., Globus Medical, Berkeley Advanced Biomaterials, Inc., Tissue Genesis, Inc., Stryker Corp, and others. Acquisition, product launches are the major strategies which are followed the by companies.

On November 2015, Bioventus acquired Bio Structures, to enlarge their surgical orthobiologics offering. Bioventus, is a worldwide leader in ortho biologic solutions has announced that it has acquired BioStructures LLC. The agreement includes the whole portfolio of product and its research and development channels.

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. MARKET METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. GROWING GERIATRIC POPULATION
3.1.2. INCREASING AWARENESS REGARDING ACCEPTANCE OF ORTHOBIOLOGICS
3.1.3. INCREASING DISPOSABLE INCOME 
3.1.4. INCREASING NUMBER OF ORTHOPAEDIC RELATED PROCEDURES 
3.1.5. BENEFITS ASSOCIATED SUCH AS REDUCED PAIN AND FASTER HEALING AND RECOVERY
3.1.6. TECHNOLOGICAL ADVANCEMENTS
3.2. MARKET RESTRAINTS 
3.2.1. HIGH COST ASSOCIATED WITH THE PRODUCTS.
3.2.2. LACK OF AWARENESS
3.3. MARKET OPPORTUNITIES
3.3.1. RISING DEMAND FROM EMERGING MARKETS 
3.3.2. RISING HEALTHCARE SPENDING BY PEOPLE ACROSS GEOGRAPHY
3.3.3. GROWING MEDICAL TOURISM 
3.4.  MARKET CHALLENGES 
3.4.1. DEARTH OF TRAINED PERSONNEL
3.4.2. TECHNOLOGICAL COMPLEXITY
 
4. MARKET SEGMENTATION 
4.1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION 2014-2023 ($ MILLION)
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBALRECONSTRUCTIVE SURGERIES MARKET 2014-2023 ($MILLION)
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.1.5.1.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL TRAUMA MARKET 2014-2023 ($MILLION)
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.1.5.2.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL SPINAL FUSION MARKET 2014-2022 ($ MILLION)
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.1.5.3.2.1.
4.1.5.3.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.4. KEY CONCLUSIONS
4.1.5.4. GLOBAL TENDON & LIGAMENT REPAIR MARKET 2014-2023 ($MILLION)
4.1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.1.5.4.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.4. KEY CONCLUSIONS
4.1.5.5. OTHER APPLICATIONS 2014-2023 ($MILLION)
4.1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.1.5.5.3. TOP PLAYERS & KEY PRODUCTS
4.1.5.5.4. KEY CONCLUSIONS
4.2. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT 2014-2023 ($MILLION)
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL DBM MARKET  2014-2023 ($MILLION)
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL ALLOGRAFT MARKET 2014-2023 ($MILLION)
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL BMP MARKET  2014-2023 ($MILLION)
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL VISCOSUPPLEMENTATION MARKET 2014-2023 ($MILLION)
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. GLOBALMACHINED BONES MARKET 2014-2023 ($MILLION)
4.2.5.5.1. APPLICATIONS
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.2.5.6. GLOBAL STEM CELL THERAPY MARKET 2014-2023 ($MILLION)
4.2.5.6.1. APPLICATIONS
4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.5. KEY CONCLUSIONS
4.2.5.7. GLOBAL OTHERS MARKET 2014-2023 ($MILLION)
4.2.5.7.1. APPLICATIONS
4.2.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
4.2.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.7.5. KEY CONCLUSIONS
4.3. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION
4.3.5.1. GLOBAL   HOSPITALS MARKET
4.3.5.1.1. APPLICATION
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL  ORTHOPEDIC CLINICS  MARKET
4.3.5.2.1. APPLICATION
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS 
4.3.5.2.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER &ACQUSITION 
5.1.2. LIST OF JOINT VENTURE
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
5.2. TOP 10 COMPANY ANALYSIS – DASHBOARD
 
6. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY REGION (REVENUE ANALYSIS), 2014-2023 ($MILLION)
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.3.1. NORTH AMERICA
6.3.1.1. INDUSTRY APPLICATION ANALYSIS
6.3.1.2. TOP COUNTRY ANALYSIS
6.3.1.2.1. U.S. 
6.3.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.1.2.1.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.1.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.3.1.2.1.4. KEY CONCLUSIONS
6.3.1.2.2. CANADA
6.3.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.1.2.2.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.1.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.3.1.2.2.4. KEY CONCLUSIONS
6.3.2. EUROPE
6.3.2.1. INDUSTRY APPLICATION ANALYSIS
6.3.2.2. TOP COUNTRY ANALYSIS
6.3.2.2.1. UK
6.3.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.2.2.1.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.2.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.1.4. KEY CONCLUSIONS
6.3.2.2.2. FRANCE
6.3.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.2.2.2.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.2.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.2.4. KEY CONCLUSIONS
6.3.2.2.3. GERMANY
6.3.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.2.2.3.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.2.2.3.3. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.3.4. KEY CONCLUSIONS
6.3.2.2.4. SPAIN
6.3.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.2.2.4.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.2.2.4.3. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.4.4. KEY CONCLUSIONS
6.3.2.2.5. ITALY 
6.3.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.2.2.5.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.2.2.5.3. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.5.4. KEY CONCLUSIONS
6.3.2.2.6. REST OF EUROPE
6.3.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.2.2.6.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.2.2.6.3. TOP PLAYERS & KEY PRODUCTS
6.3.2.2.6.4. KEY CONCLUSIONS
6.3.3. ASIA PACIFIC
6.3.3.1. INDUSTRY APPLICATION ANALYSIS
6.3.3.2. TOP COUNTRY ANALYSIS
6.3.3.2.1. CHINA
6.3.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.3.2.1.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.3.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.1.4. KEY CONCLUSIONS
6.3.3.2.2. INDIA
6.3.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.3.2.2.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.3.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.2.4. KEY CONCLUSIONS
6.3.3.2.3. JAPAN
6.3.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.3.2.3.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.3.2.3.3. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.3.4. KEY CONCLUSIONS
6.3.3.2.4. SOUTH KOREA
6.3.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.3.2.4.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.3.2.4.3. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.4.4. KEY CONCLUSIONS
6.3.3.2.5. AUSTRALIA
6.3.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.3.2.5.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.3.2.5.3. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.5.4. KEY CONCLUSIONS
6.3.3.2.6. REST OF ASIA PACIFIC
6.3.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.3.2.6.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.3.2.6.3. TOP PLAYERS & KEY PRODUCTS
6.3.3.2.6.4. KEY CONCLUSIONS
6.3.4. ROW
6.3.4.1. INDUSTRY APPLICATION ANALYSIS
6.3.4.2. TOP COUNTRY ANALYSIS
6.3.4.2.1. LATIN AMERICA
6.3.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.4.2.1.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.4.2.1.3. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.1.4. KEY CONCLUSIONS
6.3.4.2.2. MIDDLE EAST & AFRICA 
6.3.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($MILLION)
6.3.4.2.2.2. MARKET REVENUES 2014-2023 ($MILLION)
6.3.4.2.2.3. TOP PLAYERS & KEY PRODUCTS
6.3.4.2.2.4. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. BERKELEY ADVANCED BIOMATERIALS, INC.
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS 
7.1.6. STRATEGIC ANALYSIS
7.2. BAXTER INTERNATIONAL, INC
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS 
7.2.6. STRATEGIC ANALYSIS
7.3. BIOVENTUS
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS 
7.3.6. STRATEGIC ANALYSIS
7.4. BONE BIOLOGICS, INC.
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS 
7.4.6. STRATEGIC ANALYSIS
7.5. DEPUY SYNTHES, INC
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS 
7.5.6. STRATEGIC ANALYSIS
7.6. INTEGRA LIFESCIENCES CORP
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS 
7.6.6. STRATEGIC ANALYSIS
7.7. INTERVENTIONAL SPINE, INC
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS 
7.7.6. STRATEGIC ANALYSIS
7.8. MEDTRONIC, INC.
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS 
7.8.6. STRATEGIC ANALYSIS
7.9. OSIRIS THERAPEUTICS, INC.
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. PIONEER SURGICAL TECHNOLOGY
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS 
7.10.6. STRATEGIC ANALYSIS
7.11. SANOFI
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS 
7.11.6. STRATEGIC ANALYSIS
7.12. SMITH AND NEPHEW PLC
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS 
7.12.6. STRATEGIC ANALYSIS
7.13. STRYKER CORP.
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS 
7.13.6. STRATEGIC ANALYSIS
7.14. TISSUE BANKS INTERNATIONAL
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS 
7.15. TISSUE GENESIS, INC.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS 
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY APPLICATION 2014-2023 ($MILLION)
2. GLOBAL RECONSTRUCTIVE SURGERIES MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
3. GLOBAL TRAUMA MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
4. GLOBAL SPINAL FUSION MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
5. GLOBAL TENDON & LIGAMENT REPAIR MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
6. GLOBAL OTHER APPLICATIONS MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
7. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY PRODUCT 2014-2023 ($MILLION)
8. GLOBAL DBM MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
9. GLOBAL ALLOGRAFT MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
10. GLOBAL BMP MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
11. GLOBAL VISCOSUPPLEMENTATION MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
12. GLOBAL MACHINED BONES MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
13. GLOBAL STEM CELL THERAPY MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
14. GLOBAL OTHER PRODUCTS MARKET BY GEOGRAPHY 2014-2023 ($MILLION)
15. GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER 2014-2023 ($ MILLION)
16. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
17. GLOBAL  ORTHOPEDIC CLINICS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. NORTH AMERICA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
19. EUROPE ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
20. ASIA PACIFIC ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
21. REST OF THE WORLD ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
 
LIST OF FIGURES
22. GLOBAL RECONSTRUCTIVE SURGERIES MARKET 2014-2023 ($MILLION)
23. GLOBAL TRAUMA MARKET 2014-2023 ($MILLION)
24. GLOBAL SPINAL FUSION MARKET 2014-2023 ($MILLION)
25. GLOBAL TENDON & LIGAMENT REPAIR MARKET 2014-2023 ($MILLION)
26. GLOBAL OTHERS MARKET 2014-2023 ($MILLION)
27. GLOBAL DBM MARKET 2014-2023 ($MILLION)
28. GLOBAL ALLOGRAFT MARKET 2014-2023 ($MILLION)
29. GLOBAL BMP MARKET 2014-2023 ($MILLION)
30. GLOBAL VISCOSUPPLEMENTATION MARKET 2014-2023 ($MILLION)
31. GLOBAL MACHINED BONES MARKET 2014-2023 ($MILLION)
32. GLOBAL STEM CELL THERAPY MARKET 2014-2023 ($MILLION)
33. GLOBAL OTHERS MARKET GLOBAL ORTHOBIOLOGICAL PRODUCTS MARKET BY END-USER
34. GLOBAL HOSPITALS MARKET 2014-2023 ($MILLION)
35. GLOBAL ORTHOPEDIC CLINICS MARKET2014-2023 ($MILLION)
36. UNITED STATES (U.S.) ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
37. CANADA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
38. UNITED KINGDOM (UK) ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
39. FRANCE ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
40. GERMANY ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
41. SPAIN ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
42. ITALY ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
43. ROEORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
44. INDIA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
45. CHINA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
46. JAPAN ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
47. KOREA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
48. AUSTRALIA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
49. ROAPACORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
50. LATIN AMERICA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)
51. MENA ORTHOBIOLOGICAL PRODUCTS MARKET 2014-2023 ($MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

UPCOMING REPORTS

No upcoming reports available under this subcategory.

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion